Attached files
| file | filename |
|---|---|
| 8-K - 8-K - ALLERGAN INC | d729583d8k.htm |
| EX-99.2 - EX-99.2 - ALLERGAN INC | d729583dex992.htm |
Exhibit 99.1
| ALLERGAN |
| |
| 2525 Dupont Drive, P.O. Box 19534, Irvine, California, USA 92623-9534 Telephone: (714) 246-4500 Website: www.allergan.corn |
May 19, 2014
William A. Ackman
Pershing Square Capital Management, L.P.
888 Seventh Avenue, 42nd Floor
New York, NY 10019
Dear Mr. Ackman:
We confirm receipt of your letter which has been distributed to the entire Allergan, Inc. Board of Directors (the “Board of Directors”). The Board of Directors is well aware of its fiduciary duties to all stockholders and is being well-advised by its independent advisors. That being said, we strongly disagree with your statements and tactics including your blatant attempt to isolate David Pyott, who has created enormous value for the Allergan stockholders and who is keenly focused on the best interests of all stockholders. The entire Board of Directors, including David Pyott, is open to all options that will significantly enhance the long-term value of Allergan for all stockholders.
On behalf of the Board of Directors,
| /s/ Michael Gallagher |
| Michael Gallagher Lead Director |